Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Disease Exacerbation

1-methyl-3-isobutylxanthine has been researched along with Disease Exacerbation in 2 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"We show that cyclic AMP (cAMP) elevating agents protect blasts from patients with acute promyelocytic leukemia (APL) against death induced by first-line anti-leukemic anthracyclines like daunorubicin (DNR)."3.79Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis. ( Bruserud, O; Døskeland, SO; Gausdal, G; Gjertsen, BT; Havemann, U; Herfindal, L; Kleppe, R; Lanotte, M; McCormack, E; Nguyen, E; Pendino, F; Rouhee, N; Schwede, F; Ségal-Bendirdjian, E; Skavland, J; Wergeland, A, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gausdal, G1
Wergeland, A1
Skavland, J1
Nguyen, E1
Pendino, F1
Rouhee, N1
McCormack, E1
Herfindal, L1
Kleppe, R1
Havemann, U1
Schwede, F1
Bruserud, O1
Gjertsen, BT1
Lanotte, M1
Ségal-Bendirdjian, E1
Døskeland, SO1
Cox, ME1
Deeble, PD1
Lakhani, S1
Parsons, SJ1

Other Studies

2 other studies available for 1-methyl-3-isobutylxanthine and Disease Exacerbation

ArticleYear
Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis.
    Cell death & disease, 2013, Feb-28, Volume: 4

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Antibiotics, Antineoplastic; Apoptosis; bcl-Associated Death P

2013
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
    Cancer research, 1999, Aug-01, Volume: 59, Issue:15

    Topics: 1-Methyl-3-isobutylxanthine; Adenocarcinoma; Androgens; Biomarkers; Bombesin; Bucladesine; Calcium-C

1999